X
Get new exclusive access to healthcare business reports & breaking news
Marina Turea Marina is passionate about all emerging technologies in the healthcare space and love to write about all of them.
Sanofi and Inhibrx, Inc. (“Inhibrx”), a publicly traded clinical-stage biopharmaceutical company focused on developing a broad pipeline of ...
Late October, Sanofi provided a comprehensive update regarding its Play to Win strategy, continuing to focus on executing ...
Sanofi SA, the renowned French drugmaker, has announced its plans to shell out a staggering $2.9 billion to ...
The U.S. Food and Drug Administration (FDA) Center for Biologics Evaluation and Research has granted approval to Sanofi ...
Positive results proving an overall survival (OS) benefit from the Phase 3 trial investigating Sanofi and Regeneron’s PD-1 ...
Sanofi, a leading global vaccine manufacturer, has experienced a major setback in its goal of quickly producing a ...
Sanofi will give the United States priority access to a Covid-19 vaccine if and when the French pharmaceutical ...
